查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1758802

光甘草定 CAS 59870-68-7 的全球市場

Glabridin CAS 59870-68-7
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 284 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年，光甘草定 CAS 59870-68-7 的全球市場規模將達到 345 億美國

全球光甘草定（CAS 59870-68-7）市場規模預計在2024年達到275億美元，預計到2030年將達到345億美元，2024年至2030年的複合年成長率為3.8%。報告分析的細分市場之一－高效液相層析20%細分市場，預計其複合年成長率為4.9%，到分析期結束時市場規模將達到123億美元。此外，在分析期內，高效液相層析40%細分市場預計其複合年成長率為3.6%。

美國市場規模估計為 75 億美元，中國市場預計複合年成長率為 7.3%

美國光甘草定預計（CAS 59870-68-7）市場規模將在2024年達到75億美元。預計到2030年，全球第二大經濟體中國市場規模將達到70億美元，在2024-2030年的分析期間內，複合年成長率為7.3%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為1.5%和3.0%。在歐洲，預計德國市場的複合年成長率為2.2%。

全球「光甘草定 (CAS 59870-68-7)」市場趨勢及促進因素概述

為什麼光甘草定會成為化妝品和保健品產業搶手的成分？

光甘草定是一種主要從甘草根（Glycyrrhiza glabra）中提取的類黃酮化合物，因其強大的美白、抗氧化、抗炎和抗衰老功效，正迅速在全球營養保健品和化妝品行業引起關注。隨著消費者偏好轉向天然成分，光甘草定作為經科學檢驗的植物性替代物，在替代對苯二酚和曲酸等合成活性成分方面脫穎而出，尤其是在針對色素沉著過度、黃褐斑和膚色不均的護膚配方中。該化合物能夠抑制酪胺酸酶活性（酪胺酸酶是黑色素生成的關鍵），使其成為亮白護膚產品的理想成分。此外，光甘草定無刺激性，適用於敏感肌膚，並已證實具有對抗紫外線誘導的氧化壓力的保護作用，這進一步增強了效用。除了化妝品領域，光甘草定也因其雌激素、心血管和神經保護功效，正在被探索應用於機能性食品和營養保健品中。這些應用尤其適合關注女性健康和更年期問題的市場。潔淨標示配方意識的不斷提升、草本活性成分活性化的不斷加強以及新興經濟體可支配收入的不斷成長，進一步推動了市場需求。隨著自然美容和健康趨勢在亞太、歐洲和北美地區成為主流，光甘草定作為一種具有多方面健康和美容功效的優質生物活性成分，正在開拓其細分市場。

光甘草定市場的主要技術和製造趨勢是什麼？

光甘草定的萃取、精製和製劑技術創新在提高其商業性價值和擴充性發揮關鍵作用。傳統上，光甘草定是使用乙醇或水醇溶劑從甘草根中提取的，但現在受益於先進的超臨界 CO2萃取方法，可產生更高的純度並更有效地保持生物活性。這種更環保、更有效率的萃取技術符合日益成長的監管和消費者對永續採購和環保加工的需求。在製劑領域，奈米膠囊和脂質體遞送系統已被用於提高光甘草定的穩定性、生物利用度和經皮吸收。這些技術有助於克服水溶性差和局部應用中潛在分解等挑戰。在生產方面，生物技術驅動的發酵和植物細胞培養技術已成為傳統培養和提取的潛在替代方案，可在最大限度減少環境影響的同時實現可控和穩定的供應。此外，高活性含量（40% 或更高）的標準化光甘草定萃取物也正在開發中，以滿足藥品和化妝品配方的純度要求。嚴格的品管和可追溯機制正日益被採用，以確保符合安全性和功效標準，尤其是在出口到日本、韓國和歐盟方面。這些技術進步不僅使供應商能夠提高產品性能，也有助於滿足競爭激烈的全球市場對高品質、潔淨標示成分日益成長的需求。

最終用途部門和區域市場如何影響需求模式？

光甘草定市場受到幾個主要終端使用領域的強勁需求所驅動，包括化妝品和個人護理、營養保健品和藥品。在化妝品領域，光甘草定廣泛用於美白霜、抗衰老精華、防曬油和痤瘡後修復產品，使個人護理領域成為這種化合物的最大消費者。韓國、中國、日本和印度等國家在推出含有光甘草定的產品方面處於領先地位。西方市場，尤其是歐洲和北美，光甘草定在清潔美容和植物來源藥妝中的應用日益增多，在這些市場中，光甘草定通常作為優質抗衰老和敏感肌膚產品系列的一部分出售。在營養保健品領域，光甘草定被配製成補充劑，旨在管理METABOLIC INC.症候群、更年期症狀和心血管健康，這使其對老齡化社會尤其具有吸引力。藥物研究也正在探索光甘草定在發炎和荷爾蒙相關疾病中的應用，儘管其中大多數仍處於研究階段。在經銷方面，B2B（大宗萃取物供應商、化妝品原料公司）和B2C（成品品牌）通路都在不斷拓展。中國、歐盟和美國對植物萃取物監管的清晰化，進一步促進了市場准入和產品核可。電子商務的成長正在刺激跨境需求，消費者也越來越尋求有臨床依據的天然活性成分。產業創新與區域動態的融合，正在改變光甘草定在全球的定位與消費方式。

哪些因素推動了全球光甘草定市場的成長？

光甘草定 (CAS 59870-68-7) 市場的成長受到多種相互關聯的因素驅動，包括產業變化、消費行為和產品配方創新。其中最重要的是全球對天然植物來源化妝品活性成分日益成長的需求，這些成分能夠有效美化皮膚，而沒有合成成分的副作用。隨著消費者越來越注重成分，光甘草定在減少色素沉著和氧化壓力方面的已證實功效使其成為一個強大的價值提案。其次，抗衰老和美白產品日益普及，尤其是在亞太地區和中東地區，這推動了對強效植物成分的需求。第三，人口老化和對荷爾蒙平衡和代謝健康的興趣推動了機能性食品和補充劑市場的擴張，這為可攝取形式的光甘草定開闢了新的使用案例。在供應方面，萃取和生物技術的進步正在提高成本效率和擴充性，使製造商能夠在保持高純度標準的同時滿足不斷成長的全球需求。潔淨標示和純素認證產品的日益普及，也為光甘草定等植物成分創造了有利的監管和消費環境。此外，品牌在研發、臨床檢驗和行銷方面的投入，也提升了光甘草定製劑的可信度和認知度。最後，在中國、印度和中歐等全球採購基地的支持下，這種草藥成分的國際貿易正在擴大。這些綜合的市場促進因素使光甘草定成為天然化妝品和營養保健品市場的高成長成分，無論在成熟經濟體或新興經濟體，都擁有巨大的未來潛力。

部分

類型（HPLC 20%、HPLC 40%、HPLC 60%、高效液相層析90%、HPLC 98%）、用途（化妝品用途、醫藥用途）

受訪公司範例（44家值得關注的公司）

  • AIDP, Inc.
  • Alchem International
  • Alfa Chemicals
  • Anthony Ingredients
  • BOC Sciences
  • Botanic Innovations
  • ChemFaces
  • Chromadex, Inc.
  • CP Kelco
  • Euromed SA
  • FloraTech
  • Galaxy Surfactants
  • Givaudan
  • Guangxi Wuzhou Zhongheng Bio-Tech
  • Hebei Yele Biotechnology
  • Indena SpA
  • Jiangxi Shenzhou Biological
  • Layn Natural Ingredients
  • Lonza Group AG
  • Natreon, Inc.

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP36999

Global Glabridin CAS 59870-68-7 Market to Reach US$34.5 Billion by 2030

The global market for Glabridin CAS 59870-68-7 estimated at US$27.5 Billion in the year 2024, is expected to reach US$34.5 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. HPLC 20 percent, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$12.3 Billion by the end of the analysis period. Growth in the HPLC 40 percent segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.5 Billion While China is Forecast to Grow at 7.3% CAGR

The Glabridin CAS 59870-68-7 market in the U.S. is estimated at US$7.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.0 Billion by the year 2030 trailing a CAGR of 7.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global "Glabridin (CAS 59870-68-7)" Market - Key Trends & Drivers Summarized

Why Is Glabridin Emerging as a High-Demand Ingredient in the Cosmetics and Health Industry?

Glabridin, a flavonoid compound extracted primarily from licorice root (Glycyrrhiza glabra), is rapidly gaining prominence in the global nutraceutical and cosmetics industries due to its potent skin-lightening, antioxidant, anti-inflammatory, and anti-aging properties. As consumer preference shifts toward naturally derived ingredients, glabridin stands out as a scientifically validated botanical alternative to synthetic actives like hydroquinone or kojic acid, especially in skincare formulations targeting hyperpigmentation, melasma, and uneven skin tone. The compound inhibits tyrosinase activity, which is responsible for melanin production, making it a go-to ingredient in brightening and whitening skincare products. In addition, glabridin is non-irritating, suitable for sensitive skin, and has demonstrated protective effects against UV-induced oxidative stress, further reinforcing its utility in anti-aging and sun care formulations. Beyond cosmetics, glabridin is also explored in functional foods and dietary supplements for its estrogenic, cardiovascular, and neuroprotective benefits. These applications are particularly relevant in markets focused on women’s health and anti-menopausal support. The growing awareness of clean-label formulations, increased R&D into herbal actives, and rising disposable income in emerging economies are further boosting demand. As natural beauty and wellness trends become mainstream across Asia-Pacific, Europe, and North America, glabridin is carving out a niche as a premium bioactive with multifunctional health and cosmetic benefits.

What Are the Key Technological and Manufacturing Trends in the Glabridin Market?

Technological innovation in the extraction, purification, and formulation of glabridin is playing a critical role in enhancing its commercial value and scalability. Traditionally extracted from licorice root using ethanol or water-alcohol solvents, glabridin now benefits from advanced supercritical CO2 extraction methods that yield higher purity and retain bioactivity more effectively. These greener and more efficient extraction techniques align with rising regulatory and consumer demand for sustainable sourcing and environmentally friendly processing. In the realm of formulation, nanoencapsulation and liposomal delivery systems are being adopted to enhance glabridin’s stability, bioavailability, and dermal absorption. These technologies help overcome challenges like low water solubility and potential degradation in topical applications. On the production side, biotech-based fermentation and plant cell culture techniques are emerging as potential alternatives to traditional farming and extraction, enabling controlled, consistent supply while minimizing environmental impact. Manufacturers are also developing standardized glabridin extracts with high active content (≥40%) to meet the purity requirements of pharmaceutical and cosmeceutical formulations. Stringent quality control and traceability mechanisms-especially for exports to Japan, South Korea, and the European Union-are increasingly being adopted to ensure compliance with safety and efficacy standards. These technological advancements not only improve product performance but also allow suppliers to meet the growing demand for high-quality, clean-label ingredients in a competitive global market.

How Are End-Use Sectors and Geographic Markets Influencing Demand Patterns?

The glabridin market is driven by strong demand from several key end-use sectors, notably cosmetics and personal care, dietary supplements, and pharmaceuticals. In cosmetics, glabridin is used extensively in skin whitening creams, anti-aging serums, sunscreens, and post-acne recovery products-making the personal care sector the largest consumer of this compound. Asia-Pacific remains the dominant market due to cultural emphasis on skin brightness and even complexion, with countries like South Korea, China, Japan, and India leading in product launches containing glabridin. Western markets, particularly in Europe and North America, are seeing increased adoption of glabridin in clean beauty and plant-based cosmeceuticals, often marketed as part of premium anti-aging and sensitive skin product lines. In the nutraceutical sector, glabridin is incorporated into supplements aimed at managing metabolic syndrome, menopause symptoms, and cardiovascular health, appealing particularly to aging populations. Pharmaceutical research is also exploring glabridin for potential applications in inflammatory disorders and hormone-related conditions, although these remain largely in the investigational stages. In terms of distribution, both B2B (bulk extract suppliers, cosmetic ingredient companies) and B2C (finished product brands) channels are expanding. Regulatory clarity around botanical extracts in China, the EU, and the U.S. is further facilitating market entry and product approvals. E-commerce growth is accelerating demand across borders, as consumers increasingly seek natural actives with clinical backing. This convergence of industry innovation and regional dynamics is reshaping how glabridin is positioned and consumed globally.

What Factors Are Fueling Growth in the Global Glabridin Market?

The growth in the glabridin (CAS 59870-68-7) market is driven by several interconnected factors tied to industry shifts, consumer behavior, and innovation in product formulation. Foremost is the rising global demand for natural, plant-derived cosmetic actives that offer effective skin benefits without the adverse effects associated with synthetic ingredients. As consumers become more ingredient-conscious, glabridin’s proven efficacy in reducing pigmentation and oxidative stress offers a strong value proposition. Second, the increasing popularity of anti-aging and skin-brightening products-particularly in Asia-Pacific and the Middle East-is fueling demand for high-efficacy botanical ingredients, with glabridin positioned as a premium option. Third, the expansion of functional food and supplement markets-driven by the aging population and interest in hormonal balance and metabolic health-is opening new use cases for glabridin in ingestible formats. On the supply side, advancements in extraction and bioengineering technologies are improving cost-efficiency and scalability, allowing manufacturers to meet rising global demand while maintaining high purity standards. The proliferation of clean-label and vegan-certified products is also creating a favorable regulatory and consumer environment for botanical ingredients like glabridin. Additionally, brand investments in R&D, clinical validation, and marketing are strengthening the credibility and visibility of glabridin-based formulations. Finally, international trade in herbal ingredients is expanding, supported by global sourcing hubs in China, India, and Central Europe. These combined drivers are positioning glabridin as a high-growth ingredient in the broader natural cosmetics and nutraceuticals market, with strong future potential across both established and emerging economies.

SCOPE OF STUDY:

The report analyzes the Glabridin CAS 59870-68-7 market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent, HPLC 98 percent); Application (Cosmetics Application, Pharmaceuticals Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • AIDP, Inc.
  • Alchem International
  • Alfa Chemicals
  • Anthony Ingredients
  • BOC Sciences
  • Botanic Innovations
  • ChemFaces
  • Chromadex, Inc.
  • CP Kelco
  • Euromed S.A.
  • FloraTech
  • Galaxy Surfactants
  • Givaudan
  • Guangxi Wuzhou Zhongheng Bio-Tech
  • Hebei Yele Biotechnology
  • Indena S.p.A.
  • Jiangxi Shenzhou Biological
  • Layn Natural Ingredients
  • Lonza Group AG
  • Natreon, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Glabridin CAS 59870-68-7 - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Natural Skin-Lightening Agents Drives Adoption of Glabridin in Cosmetics
    • Growth in Clean Beauty and Botanical Ingredients Strengthens Market for Glabridin-Based Products
    • Scientific Research Validating Anti-Inflammatory Properties Throws Spotlight on New Therapeutic Uses
    • Expansion of Nutricosmetics Segment Accelerates Formulation of Oral Glabridin Supplements
    • Increased Consumer Preference for Non-Hydroquinone Solutions Sustains Demand for Safe Alternatives
    • Regulatory Acceptance of Plant-Based Actives Enhances Formulation Flexibility for Manufacturers
    • Growth in K-Beauty and Functional Skincare Trends Propels Use of Flavonoid-Based Ingredients
    • Limited Raw Material Sources and Cost of Purification Create Challenges in Large-Scale Production
    • Formulation Synergies with Vitamin C and Niacinamide Expand Glabridins Multi-Functional Appeal
    • E-Commerce and Indie Brand Growth Drive Inclusion in Niche Skincare Lines
    • Research into Antioxidant and Estrogenic Properties Expands Opportunities in Wellness Applications
    • High Purity Ingredient Demand from Global Markets Encourages Standardized Extraction Practices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Glabridin CAS 59870-68-7 Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for HPLC 20 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for HPLC 20 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for HPLC 20 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for HPLC 40 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for HPLC 40 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for HPLC 40 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for HPLC 60 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for HPLC 60 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for HPLC 60 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for High-Performance Liquid Chromatography 90 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for High-Performance Liquid Chromatography 90 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for High-Performance Liquid Chromatography 90 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for HPLC 98 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for HPLC 98 percent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for HPLC 98 percent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cosmetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cosmetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Cosmetics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Pharmaceuticals Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • JAPAN
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • CHINA
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • EUROPE
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • FRANCE
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • GERMANY
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • INDIA
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Glabridin CAS 59870-68-7 by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Glabridin CAS 59870-68-7 by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030
  • AFRICA
    • Glabridin CAS 59870-68-7 Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Glabridin CAS 59870-68-7 by Type - HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Glabridin CAS 59870-68-7 by Type - Percentage Breakdown of Value Sales for HPLC 20 percent, HPLC 40 percent, HPLC 60 percent, High-Performance Liquid Chromatography 90 percent and HPLC 98 percent for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Glabridin CAS 59870-68-7 by Application - Cosmetics Application and Pharmaceuticals Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Glabridin CAS 59870-68-7 by Application - Percentage Breakdown of Value Sales for Cosmetics Application and Pharmaceuticals Application for the Years 2014, 2025 & 2030

IV. COMPETITION